The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1
Curr Oncol, 32 (12)
DOI 10.3390/curroncol32120705, PubMed 41440233
StarSignDNA: mutation-to-signature attribution for accurate representation of mutational processes in low-mutation contexts
NAR Genom Bioinform, 7 (4), lqaf181
DOI 10.1093/nargab/lqaf181, PubMed 41415301
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2
J Natl Cancer Inst (in press)
DOI 10.1093/jnci/djaf363, PubMed 41403285